LEADER 01356nam0 22003133i 450 001 CAM0019051 005 20170908093319.0 010 $a9788866661504 100 $a20131022d2012 ||||0itac50 ba 101 | $aita 102 $ait 181 1$6z01$ai $bxxxe 182 1$6z01$an 200 1 $aDa baroni del Regno a grandi di Spagna$egli Acquaviva d'Atri: vita aristocratica e ambizioni politiche (secoli 15.-18.)$fGiulio Sodano 210 $aNapoli$cGuida$d2012 215 $a300 p.$d24 cm. 225 | $aPassaggi e percorsi$v25$i. Saggi$v19 225 | $aPassaggi e percorsi$v25 410 0$1001IEI0194433$12001 $aPassaggi e percorsi$i. Saggi$v19 410 0$1001IEI0194434$12001 $aPassaggi e percorsi$v25 700 1$aSodano$b, Giulio$3TSAV162745$0450999 801 3$aIT$bIT-NA0079$c20131022 850 $aIT-NA0120$aIT-NA0097 912 $aCAM0019051 950 0$aIstituto italiano per gli studi storici$d CRST MOD STUDI 2956$e CR 0000970345 B 1 v. (ex inv. 95699)$fC $h20131022$i20131022 950 0$aSocietà napoletana di storia patria$c1 v.$d SPNF. C 02479$e SP 0001724085 B (19 1 v.; dono dell'autore$fZ $h20131029$i20131029 977 $a CR$a SP 996 $aDa baroni del Regno a grandi di Spagna$91085544 997 $aUNISANNIO LEADER 03707oas 2201309 a 450 001 9910333246203321 005 20251105213014.0 011 $a1532-2084 035 $a(DE-599)ZDB2002582-8 035 $a(DE-599)2002582-8 035 $a(OCoLC)43269241 035 $a(CONSER) 00208378 035 $a(CKB)954922652203 035 $a(EXLCZ)99954922652203 100 $a19990409a19989999 sy a 101 0 $aeng 135 $aurmnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aDrug resistance updates 210 $a[London] $cHarcourt 300 $aRefereed/Peer-reviewed 311 08$a1368-7646 531 0 $aDrug resist. updates 606 $aDrug resistance in microorganisms$vPeriodicals 606 $aDrug resistance in cancer cells$vPeriodicals 606 $aDrug resistance 606 $aAnti-infective agents 606 $aDrug resistance$vPeriodicals 606 $aDrug Resistance 606 $aAntineoplastic Agents 606 $aAnti-Infective Agents 606 $aCommunicable Diseases$xdrug therapy 606 $aNeoplasms$xdrug therapy 606 $aRe?sistance aux me?dicaments$vPe?riodiques 606 $aMicro-organismes$xRe?sistance aux me?dicaments$vPe?riodiques 606 $aCellules cance?reuses$xRe?sistance aux me?dicaments$vPe?riodiques 606 $aRe?sistance aux me?dicaments 606 $aAnticance?reux 606 $aAntiinfectieux 606 $aDrug resistance$2fast$3(OCoLC)fst00898701 606 $aAnti-infective agents$2fast$3(OCoLC)fst00810345 606 $aDrug resistance in cancer cells$2fast$3(OCoLC)fst00898703 606 $aDrug resistance in microorganisms$2fast$3(OCoLC)fst00898704 608 $aPeriodical. 608 $aperiodicals.$2aat 608 $aPeriodicals.$2fast 608 $aPeriodicals.$2lcgft 608 $aPe?riodiques.$2rvmgf 615 0$aDrug resistance in microorganisms 615 0$aDrug resistance in cancer cells 615 0$aDrug resistance. 615 0$aAnti-infective agents. 615 0$aDrug resistance 615 2$aDrug Resistance. 615 2$aAntineoplastic Agents. 615 2$aAnti-Infective Agents. 615 2$aCommunicable Diseases$xdrug therapy. 615 2$aNeoplasms$xdrug therapy. 615 6$aRe?sistance aux me?dicaments 615 6$aMicro-organismes$xRe?sistance aux me?dicaments 615 6$aCellules cance?reuses$xRe?sistance aux me?dicaments 615 6$aRe?sistance aux me?dicaments. 615 6$aAnticance?reux. 615 6$aAntiinfectieux. 615 7$aDrug resistance. 615 7$aAnti-infective agents. 615 7$aDrug resistance in cancer cells. 615 7$aDrug resistance in microorganisms. 676 $a616 801 0$bCGU 801 1$bCGU 801 2$bNSD 801 2$bEYW 801 2$bOCLCQ 801 2$bGUA 801 2$bMUQ 801 2$bF#A 801 2$bOCLCQ 801 2$bAU@ 801 2$bOCLCQ 801 2$bDLC 801 2$bOCLCQ 801 2$bOPELS 801 2$bOCLCF 801 2$bVT2 801 2$bEUW 801 2$bOCLCQ 801 2$bBUF 801 2$bOCLCO 801 2$bU3W 801 2$bOCLCO 801 2$bEZC 801 2$bNJR 801 2$bWYU 801 2$bOCLCO 801 2$bNJT 801 2$bSFB 801 2$bOCLCO 801 2$bOCLCQ 801 2$bOCLCO 801 2$bCASUM 801 2$bOCLCQ 801 2$bOCL 801 2$bUAB 801 2$bOCLCL 801 2$bOCLCQ 906 $aJOURNAL 912 $a9910333246203321 996 $aDrug resistance updates$92425690 997 $aUNINA